Sercolytic: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Sercolytic
Largest movements
- Stocks and contracts -€4,938
no longer reported in 2025 (was €4,938)
- Cash +€2,455
up €2,455 (+195.5%), from €1,256 to €3,710
mainly Stocks and contracts (+€4,938) and Trade debts (+€3,367)
- Profit (loss) carried forward -€7,598
down €7,598 (-2.3%), from -€328,479 to -€336,076
- Trade debts +€3,367
up €3,367 (+321.3%), from €1,048 to €4,416
- Other debts +€1,750
up €1,750 (+0.6%), from €313,250 to €315,000
- Write-downs +€4,938
new in 2025: €4,938
- Other operating charges +€2,317
up €2,317 (+62.1%), from €3,733 to €6,050
- Gross operating margin +€2,244
up €2,244 (+189.1%), from €1,187 to €3,431
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €6,429 | €3,948 | -€2,480 | -38.6% |
| Current assets | 29/58 | €6,429 | €3,948 | -€2,480 | -38.6% |
| Stocks and contracts in progress | 3 | €4,938 | - | -€4,938 | |
| Stocks | 30/36 | €4,938 | - | -€4,938 | |
| Amounts receivable within one year | 40/41 | €235 | €238 | +€3 | +1.3% |
| Trade receivables | 40 | €124 | €124 | = | 0.0% |
| Other amounts receivable | 41 | €111 | €114 | +€3 | +2.8% |
| Cash at bank and in hand | 54/58 | €1,256 | €3,710 | +€2,455 | +195.5% |
| Total equity and liabilities | 10/49 | €6,429 | €3,948 | -€2,480 | -38.6% |
| Equity | 10/15 | -€307,870 | -€315,467 | -€7,598 | -2.5% |
| Contributions | 10/11 | €18,750 | €18,750 | = | 0.0% |
| Reserves | 13 | €1,859 | €1,859 | = | 0.0% |
| Non-distributable reserves | 130/1 | €1,859 | €1,859 | = | 0.0% |
| Reserves not available under the articles | 1311 | €1,859 | €1,859 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€328,479 | -€336,076 | -€7,598 | -2.3% |
| Amounts payable | 17/49 | €314,298 | €319,416 | +€5,117 | +1.6% |
| Amounts payable within one year | 42/48 | €314,298 | €319,416 | +€5,117 | +1.6% |
| Trade debts | 44 | €1,048 | €4,416 | +€3,367 | +321.3% |
| Suppliers | 440/4 | €1,048 | €4,416 | +€3,367 | +321.3% |
| Other amounts payable | 47/48 | €313,250 | €315,000 | +€1,750 | +0.6% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | - | €4,938 | +€4,938 | |
| Other operating charges | 640/8 | €3,733 | €6,050 | +€2,317 | +62.1% |
| Gross operating margin | 9900 | €1,187 | €3,431 | +€2,244 | +189.1% |
| Operating profit (loss) | 9901 | -€2,546 | -€7,557 | -€5,011 | -196.8% |
| Financial charges | 65/66B | €39 | €40 | +€1 | +3.5% |
| Recurring financial charges | 65 | €39 | €40 | +€1 | +3.5% |
| Profit (loss) for the period before taxes | 9903 | -€2,585 | -€7,598 | -€5,013 | -193.9% |
| Profit (loss) for the period | 9904 | -€2,585 | -€7,598 | -€5,013 | -193.9% |
| Profit (loss) for the period to be appropriated | 9905 | -€2,585 | -€7,598 | -€5,013 | -193.9% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 7 October 2026 via checked.be.